-
EClinCloud Secures New Funding to Accelerate AI Innovation in Clinical Research
•
EClinCloud (Ningbo) Technology Co., Ltd., a leading AI technology company specializing in clinical research solutions, has announced the completion of a new round of financing worth tens of millions of yuan. The investment was exclusively led by Hongfeng, a renowned biopharmaceutical investment firm. This funding will further accelerate EClinCloud’s deep…
-
Insilico Medicine Collaborates with Mabwell Bio to Enhance ADC R&D with AI
•
China’s generative artificial intelligence (AI)-driven biotech Insilico Medicine has entered into a collaboration with compatriot firm Mabwell (Shanghai) Bioscience Co., Ltd (SHA: 688062) to enhance antibody drug conjugate (ADC) product research and development (R&D). The partnership leverages the respective technical advantages of both companies in AI and ADC R&D fields,…
-
Fapon Biotech Partners with Sansure to Develop Next-Generation Diagnostic Solutions
•
China-based biotech Fapon Biotech Inc. has formed a strategic partnership with molecular diagnostics specialist Sansure Biotech Inc. (SHA: 688289). The collaboration aims to integrate Fapon’s leading artificial intelligence (AI) molecular enzyme development technology with Sansure’s extensive clinical diagnosis experience to create more accurate and reliable next-generation diagnostic solutions. Partnership DetailsThe…
-
Fapon Biotech Partners with Tencent Healthcare to Boost IVD and Medical Device Fields
•
China-based biotech Fapon Biotech Inc. has formed a strategic partnership with Tencent Healthcare, the healthcare arm of internet giant Tencent. This collaboration aims to leverage their respective resources and technical strengths in the fields of in vitro diagnosis (IVD), medical devices, and big health to drive brand building, technology cooperation,…
-
Kexing Biopharm Partners with BioMap on AI-Driven Macromolecular Drug Development
•
China-based Kexing Biopharm Co., Ltd. (SHA: 688136) announced a partnership with US biotech firm BioMap last week. The collaboration aims to develop macromolecular drugs targeting tumors and autoimmune diseases using AI technology. BioMap, an AI-based drug discovery platform, was founded by Chinese internet giant Baidu’s CEO Robin Li and Baidu…
-
China Biopharmaceutical Leads AI Integration with DeepSeek-R1
•
Since the beginning of the year, China’s self-developed AI assistant DeepSeek has made a significant splash in the global AI sector, sparking a digital revolution. Sino Biopharmaceutical Ltd (HKG: 1177), a leading biopharmaceutical company in China, has been at the forefront of integrating AI into its core strategy. The company…
-
Menarini Group Partners with VisualDx to Enhance BPDCN Identification Using AI/ML Tools
•
Italy’s Menarini Group, through its subsidiary Stemline Therapeutics Inc., has formed a partnership with US-based VisualDx. This alliance aims to enhance the identification of individuals who may have blastic plasmacytoid dendritic cell neoplasm (BPDCN) by introducing artificial intelligence/machine learning (AI/ML) tools. Understanding BPDCNBPDCN is an aggressive orphan hematologic malignancy with…
-
GE Healthcare Launches AltiX AI.i Edition for Enhanced Cardiac Procedures
•
US medical device and life sciences giant GE Healthcare Technologies Inc. (NASDAQ: GEHC) announced the introduction of the AltiX AI.i edition of Mac-Lab, CardioLab, and ComboLab. These advanced systems are designed to enhance the management of various cardiac procedures through integrated solutions and artificial intelligence. Product Integration and InnovationComboLab combines…
-
Tonghua Golden-Horse Pharmaceutical Embraces AI with DeepSeek R1 for Drug Innovation
•
Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. (SHE: 000766) recently held a special meeting to deploy the implementation of the DeepSeek R1 large model, chaired by Chairman Zhang Yufu. The company aims to accelerate the development and commercialization of the SPT-07A project through AI technology, marking a significant step in its…
-
DeepSeek’s Rise in the Pharmaceutical Industry: A New Era of AI-Driven Transformation
•
The emergence of DeepSeek-R1 during the Lunar New Year celebrations marked a pivotal moment in the adoption of affordable, open-source large language models (LLMs). This breakthrough not only lowered the barrier to entry for AI technology but also demonstrated its remarkable potential to revolutionize workflows across industries. The pharmaceutical sector…
-
Quantum Hi-Tech and ECNU Establish AI-Driven Drug Manufacturing Lab
•
CRO+CDMO Quantum Hi-Tech (China) Biotechnology Co., Ltd (ChemPartner, SHE: 300149) announced plans to establish an AI drug intelligent manufacturing joint laboratory with East China Normal University (ECNU), a comprehensive research-oriented university in Shanghai. This collaboration aims to set a new paradigm for school-enterprise cooperation in the field of AI-driven pharmaceutical…
-
Insilico Medicine Closes USD110 Million Series E Round to Advance AI-Driven Drug Pipeline
•
China’s generative artificial intelligence (AI)-driven biotech Insilico Medicine announced the completion of a USD110 million Series E financing round. The round was led by a private equity fund of Value Partners Group (HKG: 0806), with participation from Shanghai Pudong Venture Investment, Shanghai Pudong Development (Group), Wuxi Innovation Investment, and Yixing…
-
MindRank Ltd Receives FDA Clearance for MRANK-106 Clinical Study in Solid Tumors
•
China-based artificial intelligence (AI)-enabled drug developer MindRank Ltd announced receiving clearance from the US Food and Drug Administration (FDA) to initiate a clinical study for its MRANK-106, a dual inhibitor of WEE1 and YES1 kinases. This marks a significant milestone for the company as it expands its innovative oncology pipeline…
-
Nona Biosciences Launches Hu-mAtrIx: AI-Driven Engine for Accelerated Antibody Drug Discovery
•
Nona Biosciences, a wholly-owned subsidiary of HBM Holdings Ltd (HKG: 2142), announced the introduction of Hu-mAtrIx, an innovative AI-assisted drug discovery engine. This platform marks a significant advancement in the field of antibody development, leveraging cutting-edge technology to enhance efficiency and success rates. Integrated Antibody Discovery PlatformNona’s Hu-mAtrIx platform enables…
-
Roche Launches Genentech Innovation Center in Boston to Accelerate Drug Development
•
Swiss giant Roche (SWX: ROG, OTCMKTS: RHHBY) announced the launch of the Roche Genentech Innovation Center Boston at Harvard’s Enterprise Research Campus in Allston. This new facility aims to strengthen longstanding partnerships in disease biology, engineering, and artificial intelligence/machine learning. CVRM Hub and AI IntegrationThe center will serve as Roche’s…
-
SonoScape Medical Corp. Wins First AI-Powered Prenatal Ultrasound Approval in China
•
Shenzhen-based SonoScape Medical Corp. announced receiving marketing approval in China for its S-Fetus prenatal ultrasound product. This makes it the first domestic firm to gain approval for an artificial intelligence (AI)-empowered prenatal ultrasound device in the country. Technology Integration and AdvantagesThe device deeply integrates ultrasound technology and AI, representing the…
-
Insilico Medicine’s AI-Discovered Drug Rentosertib Approved for Clinical Trials
•
China’s generative artificial intelligence (AI)-driven biotech Insilico Medicine announced approval by the United States Adopted Names (USAN) Council to name its ISM001-055 as rentosertib. This groundbreaking drug candidate for idiopathic pulmonary fibrosis (IPF) represents a milestone in AI-driven drug discovery. Rentosertib’s Development and Clinical ResultsRentosertib is the world’s first drug…
-
Insilico Medicine and Tenacia Partner on AI-Driven CNS Therapies
•
China’s generative artificial intelligence (AI)-driven biotech Insilico Medicine has formed a partnership with compatriot firm Tenacia, a central nervous system (CNS) specialist incubated by Bain Capital. The collaboration aims to integrate Insilico’s cutting-edge generative AI drug discovery platform Pharma AI with Tenacia’s proprietary data assets to develop small molecule inhibitors…
-
Gensaic and Novo Nordisk Team Up to Develop Cardiometabolic Therapies
•
US-based AI-powered biotech Gensaic, Inc. announced the signing of a licensing and discovery cooperation agreement with Denmark-based Novo Nordisk A/S (NYSE: NVO). The collaboration, combining Novo’s deep therapeutic knowledge and drug development experience with Gensaic’s novel protein design technology, is designed to discover tissue-targeting ligands and develop new therapeutic candidates…
-
Baidu Health Partners with Jolly Pharma to Boost Digital Drug Marketing
•
Baidu Health, an internet giant, has entered into a partnership with Zhejiang Jolly Pharmaceutical Co., Ltd. Under the agreement, Baidu will leverage its strengths in AI and its internet medicine platform to drive digital marketing innovation for Jolly Pharma’s Bailing capsules and other drugs. The initial focus will be on…
